Worldwide Human Microbiome Market Analysis & Outlook, 2019 to 2025 - Anticipating a CAGR of 21.8%
DUBLIN, April 3, 2019 /PRNewswire/ -- The "Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product, Disease, Application, and Geography" report has been added to ResearchAndMarkets.com's offering.
The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025.
The increasing incidence of lifestyle diseases are expected to fuel the market growth during the forecast period. As per World health organization in 2016, 13% of the world population (adults) were obese.
According to the "The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation" published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity.
However, the strict government guidelines is the major concern in the human microbiome market. The strict government guidelines are intended to hamper the market to an extent. The advancements in science and technology made the scientists excited about the potential and potency of fecal matter and the microbes in it. The cell-based therapies found a novel paradigm in drug development, a regulatory framework that reports safety and bio containment issues should be established to minimize adverse events and environmental release of engineered organisms.
In recent years, for drug discovery the microbiota plays an important role in the efficacy of therapeutic compounds. There is a new phenomenon in the globe. It is the human gut microbiome and the role it may play in the future of human health. Recently various reports have indicated that the human gut microbiome may be implicated in health conditions such as obesity, metabolism, diabetes, immunity and autism.
The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. In 2017, the probiotics segment held the largest share of the market, by product. However, the prebiotics is expected to grow at the fastest CAGR during the forecast period owing to growing demand for fiber rich food products is expected to drive the market. Additionally, rising investment in the food & beverage industry for innovation and development of new food products enriched with prebiotics.
The application segment of the human microbiome market is broadly segmented into diagnostics and therapeutics. In 2017, therapeutics segment held the largest share of the market, by application. Moreover, the therapeutics segment is expected to grow at the fastest rate during the coming years owing to the increase in digestive problems, increase in the drug-related side effects, and development of therapies for chronic diseases like cancer.
Some of the major primary and secondary sources included in the report for the human microbiome market are National Cancer Institute, National Health Service, World Health Organization, Food and Drug Administration, Public Health England, and Health Protection Agency among others.
Key Topics Covered
1. Introduction
1.1. Scope of Study
1.2. Report Guidance
2. Key Takeaways
3. Human Microbiome Market Landscape
3.1. Market Overview
3.2. Market Segmentation
3.2.1. Human Microbiome Market - by Product
3.2.2. Human Microbiome Market - by Disease
3.2.3. Human Microbiome Market - by Application
3.2.4. Human Microbiome Market - by Region
3.2.4.1. by Country
3.3. Pest Analysis
3.3.1. North America - Pest Analysis
3.3.2. Europe - Pest Analysis
3.3.3. Asia Pacific - Pest Analysis
3.3.4. Middle East and Africa - Pest Analysis
3.3.5. South and Central America- Pest Analysis
4. Human Microbiome Market - Key Industry Dynamics
4.1. Key Market Drivers
4.2. Key Market Restraints
4.3. Key Market Opportunities
4.4. Clinical Trials
4.5. Impact Analysis
5. Human Microbiome Market - Global Analysis
5.1. Global Human Microbiome Market Overview
5.2. Global Human Microbiome Market Revenue Forecasts and Analysis (US$ Mn)
5.3. Market Positioning/Market Share
5.4. Performance of Key Players
5.5. Expert Opinions
6. Human Microbiome Market Revenue and Forecasts To 2025 - by Product
7. Human Microbiome Market Revenue and Forecasts To 2025 - by Disease
8. Human Microbiome Market Revenue and Forecasts To 2025 - by Application
9. North America Human Microbiome Market Revenue and Forecasts To 2025 - Country Analysis
10. Europe Human Microbiome Market Revenue and Forecasts To 2025 - Country Analysis
11. Asia Pacific Human Microbiome Market Revenue and Forecasts To 2025 - Country Analysis
12. Middle East and Africa (MEA) Human Microbiome Market Revenue and Forecasts To 2025 - Country Analysis
13. South and Central America Human Microbiome Market Revenue and Forecasts To 2025 - Country Analysis
14. Industry Landscape
14.1. Organic Growth Strategies
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. Inorganic Growth Strategies
14.2.1. Partnerships, Collaborations and Joint Ventures
14.2.2. Mergers & Acquisitions
15. Human Microbiome Market - Key Company Profiles
15.1. Enterome
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. Merck & Co. Inc.
15.3. Microbiome Therapeutics LLC
15.4. Rebiotix Inc.
15.5. Yakult Honsha Co. Ltd.
15.6. Osel Inc.
15.7. Vedanta Biosciences Inc.
15.8. Metabiomics Corporate
15.9. Synthetic Biologics Inc.
15.10. DuPont
For more information about this report visit
https://www.researchandmarkets.com/research/vk6qrr/worldwide_human?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article